Search

everythinglearnresearchcommunity

for

Search:↓

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Iron deficiency is not a significant cause of hair loss in women.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Women with female pattern hair loss have lower Vitamin D3 levels.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

More research is needed to determine if iron deficiency causes hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

An 11-month-old boy with Menkes disease had severe brain shrinkage and abnormal blood vessels, and didn't respond well to treatment.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.